First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

Completed

Conditions studied: Preeclampsia, Fetal Growth Restriction

In brief

To evaluate the feasibility of screening for preeclampsia and fetal growth restriction between 11-13+6 weeks' gestation utilizing the combination of uterine artery doppler, maternal blood pressure, maternal characteristics, placental volume, and maternal serum factors, including PAPPA-A, PLGF, AFP and free Beta HCG. This is a non interventional study.

Key facts

Study ID

NCT02379494

Run by

Fetal Medicine Foundation

People needed

1200

Starts

2013-03-01

Expected to finish

2017-01-01

Last updated by the study team

2017-08-22

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All patients during their first trimester visit

You may not qualify if…

• Fetal anomalies Pregnancies ending in termination, miscarriage or fetal death prior to 22 weeks and cases with no pregnancy follow up.

Where it is running

• Miami Valley Hospital — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.